Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Grifols, S.A Shares Outstanding 2012-2023 | GRFS

Grifols, S.A shares outstanding from 2012 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  
Grifols, S.A Annual Shares Outstanding
(Millions of Shares)
2023 677
2022 679
2021 681
2020 685
2019 685
2018 685
2017 684
2016 683
2015 686
2014 687
2013 684
2012 685
2011 556
Grifols, S.A Quarterly Shares Outstanding
(Millions of Shares)
2023-09-30 0
2023-06-30 651
2023-03-31
2022-06-30 695
2021-06-30 684
2019-06-30 690
2018-06-30 675
2017-06-30 685
2017-03-31 670
2016-12-31 683
2016-09-30 675
2016-06-30 696
2016-03-31 696
2015-12-31
2015-09-30 683
2015-06-30 682
2015-03-31 676
2014-12-31 691
2014-09-30 692
2014-06-30 692
2014-03-31 691
2013-12-31 714
2013-09-30 674
2013-06-30 673
2013-03-31 663
2012-12-31 791
2012-09-30 670
2012-06-30 693
2012-03-31 675
2011-12-31 912
2011-09-30 572
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.000B $7.134B
Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.648B 31.17
Chugai Pharmaceutical (CHGCY) Japan $57.871B 25.87
Takeda Pharmaceutical (TAK) Japan $41.080B 8.32
Merck (MKGAF) Germany $21.118B 20.48
Astellas Pharma (ALPMY) Japan $17.771B 28.06
Sandoz Group AG (SDZNY) Switzerland $15.585B 0.00
United Therapeutics (UTHR) United States $14.151B 15.09
Neurocrine Biosciences (NBIX) United States $13.594B 37.21
Shionogi (SGIOY) Japan $11.423B 9.93
Catalent (CTLT) United States $10.160B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.208B 0.00
Ionis Pharmaceuticals (IONS) United States $6.860B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.816B 7.49
Revolution Medicines (RVMD) United States $6.406B 0.00
Orion OYJ (ORINY) Finland $6.014B 25.36
Madrigal Pharmaceuticals (MDGL) United States $5.968B 0.00
Summit Therapeutics (SMMT) United States $5.623B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.561B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.538B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.337B 0.00
Corcept Therapeutics (CORT) United States $3.164B 28.67
Dyne Therapeutics (DYN) United States $2.963B 0.00
PTC Therapeutics (PTCT) United States $2.696B 0.00
Indivior (INDV) United States $2.245B 10.64
Recursion Pharmaceuticals (RXRX) United States $2.229B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.006B 11.40
Catalyst Pharmaceuticals (CPRX) United States $1.789B 17.41
NewAmsterdam Pharma (NAMS) Netherlands $1.770B 0.00
Evotec AG (EVO) Germany $1.673B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.615B 24.28
Ardelyx (ARDX) United States $1.401B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.374B 0.00
Pacira BioSciences (PCRX) United States $1.321B 12.56
Soleno Therapeutics (SLNO) United States $1.301B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.255B 0.00
Xencor (XNCR) United States $1.193B 0.00
Calliditas Therapeutics AB (CALT) Sweden $1.157B 0.00
4D Molecular Therapeutics (FDMT) United States $1.137B 0.00
Collegium Pharmaceutical (COLL) United States $1.031B 6.17
Ocular Therapeutix (OCUL) United States $1.016B 0.00
Enliven Therapeutics (ELVN) United States $1.010B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.966B 15.05
Cassava Sciences (SAVA) United States $0.925B 0.00
Relay Therapeutics (RLAY) United States $0.895B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.893B 0.00
Cronos Group (CRON) Canada $0.867B 0.00
USANA Health Sciences (USNA) United States $0.849B 13.89
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.795B 0.00
Harrow (HROW) United States $0.766B 0.00
ARS Pharmaceuticals (SPRY) United States $0.741B 0.00
Sage Therapeutics (SAGE) United States $0.656B 0.00
Exscientia (EXAI) United Kingdom $0.639B 0.00
Silence Therapeutics (SLN) United Kingdom $0.597B 0.00
Lexeo Therapeutics (LXEO) United States $0.556B 0.00
Altimmune (ALT) United States $0.525B 0.00
Savara (SVRA) United States $0.525B 0.00
Siga Technologies (SIGA) United States $0.524B 6.70
Lyell Immunopharma (LYEL) United States $0.520B 0.00
ProKidney (PROK) United States $0.511B 0.00
KalVista Pharmaceuticals (KALV) United States $0.487B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.474B 0.00
Heron Therapeutics (HRTX) United States $0.459B 0.00
Larimar Therapeutics (LRMR) United States $0.449B 0.00
OmniAb (OABI) United States $0.446B 0.00
Verve Therapeutics (VERV) United States $0.439B 0.00
Bioventus (BVS) United States $0.434B 16.61
Theravance Biopharma (TBPH) Cayman Islands $0.409B 0.00
Esperion Therapeutics (ESPR) United States $0.396B 0.00
Tourmaline Bio (TRML) United States $0.364B 0.00
Organogenesis (ORGO) United States $0.331B 62.50
Xeris Biopharma Holdings (XERS) United States $0.311B 0.00
Korro Bio (KRRO) United States $0.310B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.299B 0.00
Nature's Sunshine Products (NATR) United States $0.281B 17.86
Black Diamond Therapeutics (BDTX) United States $0.264B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.259B 0.00
Nanobiotix S.A (NBTX) France $0.230B 0.00
Foghorn Therapeutics (FHTX) United States $0.223B 0.00
Century Therapeutics (IPSC) United States $0.216B 0.00
ESSA Pharma (EPIX) Canada $0.215B 0.00
Incannex Healthcare (IXHL) Australia $0.214B 0.00
Eliem Therapeutics (ELYM) United States $0.213B 0.00
Aquestive Therapeutics (AQST) United States $0.210B 0.00
Prelude Therapeutics (PRLD) United States $0.208B 0.00
Fractyl Health (GUTS) United States $0.207B 0.00
Profound Medical (PROF) Canada $0.207B 0.00
Avita Medical (RCEL) United States $0.205B 0.00
Innate Pharma SA (IPHYF) France $0.200B 0.00
Aldeyra Therapeutics (ALDX) United States $0.198B 0.00
Nektar Therapeutics (NKTR) United States $0.197B 0.00
Elite Pharmaceuticals (ELTP) United States $0.195B 18.28
Zevra Therapeutics (ZVRA) United States $0.192B 0.00
Acrivon Therapeutics (ACRV) United States $0.187B 0.00
Pyxis Oncology (PYXS) United States $0.180B 0.00
Akebia Therapeutics (AKBA) United States $0.180B 0.00
Adherex Technologies (FENC) United States $0.169B 206.67
Context Therapeutics (CNTX) United States $0.164B 0.00
Achieve Life Sciences (ACHV) Canada $0.159B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.148B 0.00
Cardiol Therapeutics (CRDL) Canada $0.146B 0.00
Regulus Therapeutics (RGLS) United States $0.140B 0.00
Metagenomi (MGX) United States $0.140B 0.00
Galectin Therapeutics (GALT) United States $0.139B 0.00
CytoDyn (CYDY) United States $0.137B 0.00
Karyopharm Therapeutics (KPTI) United States $0.136B 0.00
MediWound (MDWD) Israel $0.136B 0.00
Telomir Pharmaceuticals (TELO) United States $0.133B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.126B 8.41
VAXART, INC (VXRT) United States $0.122B 0.00
Citius Pharmaceuticals (CTXR) United States $0.121B 0.00
OptiNose (OPTN) United States $0.116B 0.00
FibroGen (FGEN) United States $0.116B 0.00
Assertio Holdings (ASRT) United States $0.114B 5.22
Journey Medical (DERM) United States $0.100B 0.00
Aclaris Therapeutics (ACRS) United States $0.092B 0.00
Conduit Pharmaceuticals (CDT) United States $0.091B 0.00
Relmada Therapeutics (RLMD) United States $0.090B 0.00
AlloVir (ALVR) United States $0.089B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
PMV Pharmaceuticals (PMVP) United States $0.086B 0.00
ProPhase Labs (PRPH) United States $0.082B 0.00
Arch Biopartners (ACHFF) Canada $0.078B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.075B 0.00
SCYNEXIS (SCYX) United States $0.071B 1.01
Vivani Medical (VANI) United States $0.070B 0.00
Champions Oncology (CSBR) United States $0.067B 0.00
Nutriband (NTRB) United States $0.058B 0.00
Mural Oncology (MURA) Ireland $0.055B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.054B 0.00
CASI Pharmaceuticals (CASI) China $0.049B 0.00
Carisma Therapeutics (CARM) United States $0.048B 0.00
BioLineRx (BLRX) Israel $0.046B 0.00
Tempest Therapeutics (TPST) United States $0.046B 0.00
Inotiv (NOTV) United States $0.045B 0.00
DURECT (DRRX) United States $0.044B 0.00
Lipocine (LPCN) United States $0.044B 0.00
Protara Therapeutics (TARA) United States $0.043B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.041B 0.00
Natural Alternatives (NAII) United States $0.039B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.035B 0.00
Rafael Holdings (RFL) United States $0.035B 0.00
Surrozen (SRZN) United States $0.032B 0.00
NRx Pharmaceuticals (NRXP) United States $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
BioVie (BIVI) United States $0.027B 0.00
VYNE Therapeutics (VYNE) United States $0.025B 0.00
Aptorum Group (APM) United Kingdom $0.025B 0.00
SHINECO (SISI) China $0.024B 0.00
Gain Therapeutics (GANX) United States $0.023B 0.00
Oncternal Therapeutics (ONCT) United States $0.023B 0.00
Viracta Therapeutics (VIRX) United States $0.022B 0.00
Minerva Neurosciences (NERV) United States $0.022B 0.00
GlycoMimetics (GLYC) United States $0.022B 0.00
TherapeuticsMD (TXMD) United States $0.021B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.021B 0.00
Iterum Therapeutics (ITRM) Ireland $0.020B 0.00
JanOne (JAN) United States $0.019B 0.00
MEI Pharma (MEIP) United States $0.019B 0.73
Unicycive Therapeutics (UNCY) United States $0.019B 0.00
Jaguar Animal Health (JAGX) United States $0.019B 0.00
PolyPid (PYPD) Israel $0.019B 0.00
Indaptus Therapeutics (INDP) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.017B 0.00
Lyra Therapeutics (LYRA) United States $0.016B 0.00
Avalo Therapeutics (AVTX) United States $0.014B 0.00
Talphera (TLPH) United States $0.014B 0.00
Mannatech (MTEX) United States $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
Redhill Biopharma (RDHL) Israel $0.011B 0.00
Dominari Holdings (DOMH) United States $0.011B 0.00
Traws Pharma (TRAW) United States $0.011B 0.00
Alaunos Therapeutics (TCRT) United States $0.011B 0.00
Cosmos Health (COSM) Greece $0.011B 0.00
Inhibikase Therapeutics (IKT) United States $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.009B 0.00
Universe Pharmaceuticals INC (UPC) China $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Molecular Templates (MTEM) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Ainos (AIMD) United States $0.005B 0.00
CERo Therapeutics Holdings (CERO) United States $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Qualigen Therapeutics (QLGN) United States $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.05
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 29.19